These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22345301)

  • 41. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
    Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
    Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA in lung cancer diagnostics and treatment.
    Skrzypski M; Dziadziuszko R; Jassem J
    Mutat Res; 2011 Dec; 717(1-2):25-31. PubMed ID: 21540042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.
    Cho WC
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review.
    Zhou G; Shi X; Zhang J; Wu S; Zhao J
    J Int Med Res; 2013 Feb; 41(1):1-12. PubMed ID: 23569124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment.
    Feng B; Zhang K; Wang R; Chen L
    Clin Sci (Lond); 2015 May; 128(10):619-34. PubMed ID: 25760961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNAs as prognostic markers in ovarian cancer.
    Llauradó M; Majem B; Altadill T; Lanau L; Castellví J; Sánchez-Iglesias JL; Cabrera S; De la Torre J; Díaz-Feijoo B; Pérez-Benavente A; Colás E; Olivan M; Doll A; Alameda F; Matias-Guiu X; Moreno-Bueno G; Carey MS; Del Campo JM; Gil-Moreno A; Reventós J; Rigau M
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):73-84. PubMed ID: 24747602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In-depth bioinformatic analysis of lung cancer-associated microRNA targets.
    Zhang H; Yang H; Zhang R; Zhang C; Zhang J; Li D
    Oncol Rep; 2013 Dec; 30(6):2945-56. PubMed ID: 24085243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A Review of Epigenetic Modifications Regulate MicroRNA Expression in Lung Cancer].
    Hu X; Tian K
    Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):582-588. PubMed ID: 32702792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Circulating microRNAs in lung cancer: prospects for diagnostics, prognosis and prediction of antitumor treatment efficiency].
    Vlasov VV; Rykova EIu; Ponomareva AA; Zaporozhchenko IA; Morozkin ES; Cherdyntseva NV; Laktionov PP
    Mol Biol (Mosk); 2015; 49(1):55-66. PubMed ID: 25916110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNAs in Lung Cancer and Lung Cancer Bone Metastases: Biomarkers for Early Diagnosis and Targets for Treatment.
    Zhao Q; Li P; Ma J; Yu X
    Recent Pat Anticancer Drug Discov; 2015; 10(2):182-200. PubMed ID: 25600282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted Therapy.
    Zheng N; Yang P; Wang Z; Zhou Q
    Curr Cancer Drug Targets; 2017; 17(1):40-47. PubMed ID: 26881930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis.
    Vannini I; Fanini F; Fabbri M
    Clin Biochem; 2013 Jul; 46(10-11):918-25. PubMed ID: 23396164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An Overview on the Role of miR-451 in Lung Cancer: Diagnosis, Therapy, and Prognosis.
    Soofiyani SR; Hosseini K; Soleimanian A; Abkhooei L; Hoseini AM; Tarhriz V; Ghasemnejad T
    Microrna; 2021; 10(3):181-190. PubMed ID: 34514995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. microRNA detection in feces, sputum, pleural effusion and urine: novel tools for cancer screening (Review).
    Xiao YF; Yong X; Fan YH; Lü MH; Yang SM; Hu CJ
    Oncol Rep; 2013 Aug; 30(2):535-44. PubMed ID: 23754129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance.
    Iqbal MA; Arora S; Prakasam G; Calin GA; Syed MA
    Mol Aspects Med; 2019 Dec; 70():3-20. PubMed ID: 30102929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic alteration regulated by microRNAs in biliary tract cancers.
    Wang N; Xia S; Chen K; Xiang X; Zhu A
    Crit Rev Oncol Hematol; 2015 Nov; 96(2):262-73. PubMed ID: 26095617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer.
    Tutar Y; Özgür A; Tutar E; Tutar L; Pulliero A; Izzotti A
    Biomed Pharmacother; 2016 Oct; 83():1182-1190. PubMed ID: 27551766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Roles of microRNAs in lymphocytopoiesis and lymphoid malignancies - review].
    Zhu MX; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):1014-9. PubMed ID: 22931675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Critical microRNAs in Lung Cancer: Recent Advances and Potential Applications.
    Zarredar H; Ansarin K; Baradaran B; Shekari N; Eyvazi S; Safari F; Farajnia S
    Anticancer Agents Med Chem; 2018; 18(14):1991-2005. PubMed ID: 30088452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor suppressor microRNAs: a novel non-coding alliance against cancer.
    Blandino G; Fazi F; Donzelli S; Kedmi M; Sas-Chen A; Muti P; Strano S; Yarden Y
    FEBS Lett; 2014 Aug; 588(16):2639-52. PubMed ID: 24681102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.